Author details

Full Name

Carsten Skarke

Affiliation

University of Pennsylvania.

ORCID

Career Start Year

1995

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36824952	Diurnal rhythmicity of wearable device-measured wrist temperature predicts future disease incidence in the UK Biobank.	Res Sq	2023
37808824	Evidence for a role of human blood-borne factors in mediating age-associated changes in molecular circadian rhythms.	bioRxiv	2023
37620332	Diurnal rhythms of wrist temperature are associated with future disease risk in the UK Biobank.	Nat Commun	2023
37689782	Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms.	Nat Commun	2023
37105582	Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs.	J Pharmacol Exp Ther	2023
37205602	Prognostic utility of rhythmic components in 24-hour ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity.	medRxiv	2023
34724846	Nitecap: An Exploratory Circadian Analysis Web Application.	J Biol Rhythms	2022
35332134	No increase in inflammation in late-life major depression screened to exclude physical illness.	Transl Psychiatry	2022
33342316	Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.	Chronobiol Int	2021
34976917	Considerations for the Safe Operation of Schools During the Coronavirus Pandemic.	Front Public Health	2021
32812805	Diet-Epigenome Axis.	Circ Genom Precis Med	2020
29290411	CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis.	EBioMedicine	2018
29215023	A Pilot Characterization of the Human Chronobiome.	Sci Rep	2017
29107287	Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.	Mol Metab	2017
26180051	Bioactive products formed in humans from fish oils.	J Lipid Res	2015
26332979	Molecular clocks and the human condition: approaching their characterization in human physiology and disease.	Diabetes Obes Metab	2015
25450471	Selective COX-2 inhibitors suppress prostacyclin.	Clin Ther	2014
23092618	Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(Â®)) of Boswellia extract.	Fitoterapia	2013
27121942	GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose-Exposure Relationships to Define Clinical Development Strategies.	Clin Pharmacol Drug Dev	2013
23775505	Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.	Naunyn Schmiedebergs Arch Pharmacol	2013
22167571	Increased bioavailability of 11-keto-Î²-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures.	J Clin Pharmacol	2012
23150076	Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats.	Planta Med	2012
22278334	Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649.	Clin Pharmacol Ther	2012
20375362	Training translators for smart drug discovery.	Sci Transl Med	2010
19374837	On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.	Eur J Pharmacol	2009
19648270	Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense.	J Immunol	2009
18085997	Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance.	Pharmacogenomics	2007
17916229	Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.	J Thromb Haemost	2007
16515396	Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.	Pharmacogenomics	2006
17178263	The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.	Clin Pharmacol Ther	2006
16413243	Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.	Clin Pharmacol Ther	2006
16413240	Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.	Clin Pharmacol Ther	2006
15704610	Comparison of two screening methods for in-house genotyping in clinical pharmacology units.	Int J Clin Pharmacol Ther	2005
16153398	The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.	Clin Pharmacol Ther	2005
16307269	Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.	Eur J Clin Pharmacol	2005
15830250	[Fundamental principles of clinical trials].	Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz	2005
15982815	Is morphine-3-glucuronide of therapeutic relevance?	Pain	2005
15049432	Single-step identification of all length polymorphisms in the UGT1A1 gene promoter.	Int J Clin Pharmacol Ther	2004
15530129	Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.	Clin Pharmacokinet	2004
15564947	Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humans.	Anesthesiology	2004
14981031	Comprehensive mu-opioid-receptor genotyping by pyrosequencing.	Clin Chem	2004
12545149	Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.	Clin Pharmacol Ther	2003
12895198	Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome.	Br J Clin Pharmacol	2003
14559207	Simultaneous screening for three mutations in the ABCB1 gene.	Genomics	2003
14594747	Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.	Am J Psychiatry	2003
14534517	Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine.	Clin Pharmacol Ther	2003
14583678	Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers.	Pharmacogenetics	2003
11773859	The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.	Pharmacogenetics	2002
12189362	Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.	Clin Pharmacol Ther	2002
12357145	Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?	Anesthesiology	2002

1 - 50 of 61

Saurabh Aggarwal

University of Alabama at Birmingham

Career Start Year 2009

Number of shared co-authors 0

Paola Nicoletti

Icahn School of Medicine at Mount Sinai

Career Start Year 2005

Number of shared co-authors 1

Li Gong

Stanford University

Career Start Year 2004

Number of shared co-authors 5

Bradley L Urquhart

Schulich School of Medicine and Dentistry, Western University

Career Start Year 2003

Number of shared co-authors 0

Xin-Qun Wang

University of Virginia Health System

Career Start Year 2001

Number of shared co-authors 1

Samuel M Poloyac

University of Texas

Career Start Year 1999

Number of shared co-authors 0

Taimour Y Langaee

Center for Pharmacogenomics and Precision Medicine, University of Florida

Career Start Year 1998

Number of shared co-authors 2

Douglas Hayden

Massachusetts General Hospital.

Career Start Year 1997

Number of shared co-authors 0

Sony Tuteja

University of Pennsylvania Perelman School of Medicine

Career Start Year 1996

Number of shared co-authors 4

Brinda K Rana

University of California

Career Start Year 1996

Number of shared co-authors 0

Deanna L Kroetz

University of California San Francisco

Career Start Year 1993

Number of shared co-authors 1

Huy Nguyen

The University of Danang-University of Science and Technology

Career Start Year 1993

Number of shared co-authors 0

Xi-Ping Huang

University of North Carolina School of Medicine

Career Start Year 1992

Number of shared co-authors 0

Kazuhiro Kosuge

Center for Transformative AI and Robotics, Tohoku University

Career Start Year 1992

Number of shared co-authors 0

Daniel A Brazeau

Marshall University, Joan C. Edwards School of Medicine

Career Start Year 1992

Number of shared co-authors 0

Bruce C Carleton

BC Children's Hospital Research Institute

Career Start Year 1991

Number of shared co-authors 0

Saeed A Jortani

University of Louisville

Career Start Year 1991

Number of shared co-authors 0

Russell A Wilke

University of South Dakota Sanford School of Medicine

Career Start Year 1989

Number of shared co-authors 5

Robert L Fitzgerald

university of california san diego Health, Center for Advanced Laboratory Medicine

Career Start Year 1988

Number of shared co-authors 0

Christopher M Frampton

University of Otago

Career Start Year 1986

Number of shared co-authors 0

John L Black

Mayo Clinic

Career Start Year 1985

Number of shared co-authors 2

Karen Byth

Westmead Hospital

Career Start Year 1983

Number of shared co-authors 0

Charles M Stein

Vanderbilt University School of Medicine

Career Start Year 1982

Number of shared co-authors 7

Lawrence J Lesko

Department of Pharmaceutics, University of Florida

Career Start Year 1979

Number of shared co-authors 0

David A Schoenfeld

Mass General Hospital

Career Start Year 1977

Number of shared co-authors 0

Alastair J J Wood

Vanderbilt University

Career Start Year 1974

Number of shared co-authors 1

Brian L Strom

Center for Pharmacoepidemiology and Treatment Science, Rutgers University

Career Start Year 1970

Number of shared co-authors 1

Guilherme Suarez-Kurtz

Instituto Nacional de Cancer

Career Start Year 1968

Number of shared co-authors 1

Leslie M Shaw

Perelman School of Medicine, University of Pennsylvania

Career Start Year 1968

Number of shared co-authors 0

Wolfgang Sad??e

College of Medicine, The Ohio State University

Career Start Year 1967

Number of shared co-authors 1

row(s) 1 - 30 of 30

Garret A FitzGerald

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 15

Gregory R Grant

Perelman School of Medicine, University of Pennsylvania Philadelphia

Co-authored papers 7

Nicholas F Lahens

University of Pennsylvania.

Co-authored papers 6

Aalim M Weljie

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 3

Casey S Greene

Co-authored papers 2

Tilo Grosser

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 2

Casey S Greene

Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine

Co-authored papers 2

Ronan Lordan

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 2

Amruta Naik

Children's Hospital of Philadelphia

Co-authored papers 2

Muredach P Reilly

Vagelos College of Physicians and Surgeons, Columbia University

Co-authored papers 1

Milton Pividori

Perelman School of Medicine, University of Pennsylvania